Literature DB >> 7107952

Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.

A Hodgkinson, T Thompson.   

Abstract

Conditions for the determination of the fasting urinary hydroxyproline: creatinine ratio (OHPr: Cr ratio) have been examined, using a resin-catalysed hydrolysis and automated colorimetric procedure for the determination of hydroxyproline. Feeding experiments with gelatin showed that hydroxyproline is rapidly absorbed and excreted in the urine and that a 12-hour (overnight) fast is sufficient to ensure correct and reproducible fasting OHPr: Cr ratios. The mean fasting OHPr: Cr ratio decreased slightly with increasing age in both men and premenopausal women but there was no significant difference between the sexes. There was, however, a significant increase in the mean ratio in postmenopausal women. The normal range of fasting OHPr: Cr ratios for men and premenopausal women was found to be 0.003--0.015.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107952      PMCID: PMC497793          DOI: 10.1136/jcp.35.8.807

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  A simplified method for the estimation of urinary total hydroxyproline.

Authors:  B T Nobbs; A W Walker; T J Davies
Journal:  Clin Chim Acta       Date:  1975-10-15       Impact factor: 3.786

2.  ESTIMATION OF HYDROXYPROLINE BY THE AUTOANALYSER.

Authors:  R A GRANT
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

Review 3.  URINARY HYDROXYPROLINE EXCRETION AND GROWTH.

Authors:  J D SMILEY; M ZIFF
Journal:  Physiol Rev       Date:  1964-01       Impact factor: 37.312

4.  HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.

Authors:  F L BENOIT; G B THEIL; R H WATTEN
Journal:  Metabolism       Date:  1963-12       Impact factor: 8.694

5.  A specific method for the analysis of hydroxyproline in tissues and urine.

Authors:  D J PROCKOP; S UDENFRIEND
Journal:  Anal Biochem       Date:  1960-11       Impact factor: 3.365

6.  Gastrointestinal absorption and renal excretion of hydroxyproline peptides.

Authors:  D J PROCKOP; H R KEISER; A SJOERDSMA
Journal:  Lancet       Date:  1962-09-15       Impact factor: 79.321

7.  Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis.

Authors:  B C Goverde; F J Veenkamp
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

8.  Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculus.

Authors:  L Bulusu; A Hodgkinson; B E Nordin; M Peacock
Journal:  Clin Sci       Date:  1970-05       Impact factor: 6.124

9.  The influence of age and weight on the urinary excretion of hydroxyproline and calcium.

Authors:  A E Saleh; J M Coenegracht
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

10.  [HYDROXYPROLINE CONTENT OF BLOOD SERUM IN NORMAL PERSONS AND SILICOSIS PATIENTS].

Authors:  H BAUMANN; E FRITZE; C KALLWEIT
Journal:  Klin Wochenschr       Date:  1964-08-15
View more
  10 in total

1.  Nondestructive measurement of bone mineral in femurs from ovariectomized rats.

Authors:  D B Kimmel; T J Wronski
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

2.  Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.

Authors:  C J Gibbs; J E Aaron; M Peacock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

3.  Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism.

Authors:  A G Need; H A Morris; M Horowitz; B E Nordin
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

4.  Bone mass as referent for urinary hydroxyproline excretion: age and sex-related changes in 125 normals and in primary hyperparathyroidism.

Authors:  L Hyldstrup; P McNair; G F Jensen; H R Nielsen; I Transbøl
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

5.  Radiographic hand osteoarthritis and serum levels of osteocalcin: cross-sectional study.

Authors:  Leonid Kalichman; Eugene Kobyliansky
Journal:  Rheumatol Int       Date:  2010-02-16       Impact factor: 2.631

6.  Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.

Authors:  K Näntö-Salonen; S Autio; E Härö; T Kivimäki; S L Koskela; V Näntö; R Penttinen
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.

Authors:  S J Wimalawansa; R D Gunasekera
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

8.  Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats.

Authors:  T Takagi; T Yamamoto; S Asano; H Tamaki
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

9.  An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.

Authors:  A B Hodsman; L J Fraher; T Ostbye; J D Adachi; B M Steer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Bone density in women receiving depot medroxyprogesterone acetate for contraception.

Authors:  T Cundy; M Evans; H Roberts; D Wattie; R Ames; I R Reid
Journal:  BMJ       Date:  1991-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.